Yet, high NfL and reduced Aβ42 in plasma have been associated with risk of clinical all-cause dementia and Alzheimer’s disease in non-demented individuals in our cohort10, suggesting they may reflect neurodegenerative disease in a preclinical phase. Here, NEFL is linked to neurodegenerative disease.